A team of high school journalists on what's working — and what isn't — with Oregon's new ban on cell phones in schools.

INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and ...

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...

Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...

By analyzing the tumor environment of diffuse large B-cell lymphoma (DLBCL), researchers from The University of Texas MD ...

“Utilizing real-world data, technology, strategic solutions, and cross-departmental partnerships will help ensure equitable access, so the right member receives the right drug at the right time and ...

Molecular analysis identified ABC and GCB subtypes, with the ABC subtype benefiting more from the new regimen. The identification of biomarkers in frontline diffuse large B-cell lymphoma (DLBCL) is ...

For two years, during the height of the pandemic, Nikita Thomas sat in a Fulton County jail cell in Union City trying to stay ...